SCHEMBL29190795

SCHEMBL29190795

NC(=O)c1cc2cc(C(F)(F)F)cnc2cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.57
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ LCK P06239 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ SCN10A Q9Y5Y9 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ PARP1 P09874 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PLAU P00749 1/20 0.38
▸ AGBL2 Q5U5Z8 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1996711 0.73 KMT2A (1.00) KMT2APARP1MAPK1SMN1; SMN2LMNA
SCHEMBL5173369 0.71 LCK (0.56) KMT2ALCKPARP1SMN1; SMN2LMNA
SCHEMBL30310860 0.71 KMT2A (0.55) KMT2AALDH1A1PARP1MAPK1KDM4E
SCHEMBL7449066 0.71 KMT2A (0.47) KMT2APARP1MAPK1KDM4E
SCHEMBL29925974 0.70 LCK (0.45) KMT2ALCKLMNA
SCHEMBL22411383 0.70 KMT2A (0.43) KMT2ACYP1A2CYP2C19ALDH1A1GAA
SCHEMBL7145196 0.69 LCK (0.47) KMT2ACYP1A2LCKALDH1A1MAPT
SCHEMBL24506792 0.69 HTR1D (0.33) —
SCHEMBL18372036 0.69 SMN1; SMN2 (0.49) AGBL2SMN1; SMN2HTTRAB9A
SCHEMBL29921698 0.68 KMT2A (0.51) KMT2ACYP1A2CYP2C19ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113631535-B Heteroaryl and bisheteroaryl derivatives for the treatment of iron death-related disorders 协同医药发展有限公司 2024-04-12 — — CN disclosed
Send feedback